October 2002

Pacemakers, Cardiac, External, Noninvasive

Electrodes; Invasive Electrodes,
Transesophageal
Scope of this Product Comparison
This Product Comparison covers external noninva-
sive and transesophageal pacemakers that function
in fixed-rate (asynchronous) and/or demand modes,
provide adjustable pulse rates and output currents,
and include an electrocardiogram (ECG) monitor or
ECG output adapter. These devices are also re-
ferred to as noninvasive temporary pacemakers or
transcutaneous pacemakers.
For specifications of external noninvasive pace-
makers that are part of battery-powered defibrilla-
tor/pacemakers, see the Product Comparisons titled
DEFIBRILLATORS, EXTERNAL, MANUAL; DEFIBRIL-
LATOR/PACEMAKERS, EXTERNAL and DEFIBRILLA-
TORS, EXTERNAL, AUTOMATED; SEMIAUTOMATED.
For information on other types of cardiac pace-
makers, see the reports on PACEMAKERS, CARDIAC,
EXTERNAL, INVASIVE ELECTRODES, TRANSVENOUS
and PACEMAKERS, CARDIAC, IMPLANTABLE.
Purpose
External noninvasive pacemakers generate electri-
cal impulses that are delivered through externally
applied electrodes and that stimulate all chambers of
the heart simultaneously (in contrast to single- or
dual-chambered invasive pacing) to assist in resusci-
tating patients, to correct arrhythmias, or to tempo-
rarily pace during invasive procedures that might
inadvertently induce bradyrhythmias or asystole.
When healthy, the heart is stimulated to contract by
a group of specialized myocardial cells, called the sinoa-
trial (SA) node, located at the junction of the superior
vena cava and the right atrium. The SA node generates
a spontaneous electrical stimulus that is conducted
through the atria and causes them to contract; thus,

UMDNS information
This Product Comparison covers the following
device terms and product codes as listed in ECRIs
Universal Medical Device Nomenclature System
(UMDNS):
Pacemakers, Cardiac, External, Invasive Elec-
trodes, Transesophageal [17-494]
Pacemakers, Cardiac, External, Noninvasive
Electrodes [16-516] Transesophageal pacer

181009 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, USA

424-008 Telephone +1 (610) 825-6000 Fax +1 (610) 834-1275 E-mail hpcs@ecri.org
Healthcare Product Comparison System
the SA node is the hearts natural pacemaker. The
electrical stimulus is transmitted to the atrioventricu-
lar (AV) node, located in the septal wall of the right
atrium, which then stimulates the ventricles to con-
tract (see Fig. 1).
Compared to transvenous pacing (in which a pacing
lead is inserted through a vein into the heart), external
noninvasive pacing is preferred in some emergency
situations because it can be applied more quickly and
easily and does not require the skills of a physician. It
can be used by emergency medical services for prehos-
pital therapy and/or during transport and is indicated
for emergency temporary treatment of asystole, severe
bradycardia, SA node dysfunction (also called sick-si-
nus syndrome, or SSS), implantable pacemaker fail-
ure, certain types of tachycardia, and acute myocardial
infarction.
External noninvasive pacemakers can also provide
backup pacing during surgical placement of pacemak-
ers and temporary and permanent pacemaker leads.
During other types of surgery, external noninvasive
pacing can serve as a standby therapy for patients
predisposed to cardiac disorders. Noninvasive pacing
has also been used in place of certain resuscitative
drug therapies (see the American Heart Association
citation in Standards and Guidelines).
Transesophageal pacing stimulates only the atrial
chambers of the heart; it is used primarily in the
diagnosis and temporary treatment of atrial arrhyth-
mias but can also be used to induce cardiac stress for
ECG diagnosis of heart disease.
Principles of operation
External noninvasive and transesophageal pace-
makers generate repetitive electrical stimuli. Their
electronic circuitry controls the pulse rate and output
current. To condition ECG input signals for output to
a monitor, external noninvasive pacemakers attenu-
ate or blank the high-amplitude pacing stimulus. The
ECG can then be displayed on an integral ECG monitor
or a monitor connected to the pacemakers ECG output
adapter that senses and displays only the hearts in-
trinsic electrical response rhythm. The blanked period
is indicated by two markers on the ECG waveform.
Some models use a stimulus suppressor to regulate the
amount of blanking needed. Without this blanking, the
pacing stimulus would obscure the ECG waveform.
During resuscitation or other use, an external non-
invasive pacemaker is connected through a two-lead
cable to two large-surface, pregelled, disposable adhe-
sive electrodes. Electric current from the pacemaker is
conducted across the skin from one electrode to the
2 2002 ECRI. Duplication of this page by any means for any purpose is prohibited.
other electrode. As current flows between the elec-
trodes, part of it should be conducted through the
heart, inducing it to contract. The electrodes are ap-
plied in either the anterior-posterior position one
electrode over the heart and one directly behind it
or the anterior-anterior position one electrode near
the apex of the heart and one on the right chest below
the clavicle (see Fig. 2). The anterior-posterior position
is generally preferred because it reduces pectoral mus-
cle stimulation and does not interfere with defibrilla-
tor paddle placement. Multifunction electrodes that
allow pacing, defibrillation, and monitoring are some-
times used. Electrodes are sometimes left in place for
24 to 72 hours; however, manufacturers may have
specific instructions for their particular model.
Electrodes for transesophageal pacing are inserted
transnasally (bipolar catheter) or are swallowed (bipo-
lar catheter or pill electrode) to a predetermined depth,
approximately at the esophageal-gastric junction be-
yond the atrium. The electrode must then be gradually
withdrawn until the maximum P-wave (representing
the depolarization of the atria) is detected. Radio-
graphic imaging can be used to confirm correct elec-
trode placement.
When the pacemaker is turned on, current is ad-
justed until pacing occurs. The clinician can confirm
capture (stimulation resulting in heart contraction)
when a one-to-one ratio between the pacing stimulus
and the QRS complex is detected; however, signs of
improved perfusion such as pulse strength and/or
skin color and temperature, blood pressure, and level
of consciousness should also be used.
SA Node Left Atrium
Left
AV Ventricle
Node
Right
Atrium Bundles
of His
Right
Ventricle
C158UN2C
Purkinje Fibers
Figure 1. Structures involved in the conduction of
electrical stimuli through the heart

Figure 2. Electrode positions
Pacing threshold, the minimum current amplitude
necessary to achieve capture, is affected by the condi-
tion of the myocardium, electrode placement, and pulse
width (the duration of the pulse stimulus) and typically
decreases as therapy continues and the heart becomes
perfused. Current amplitude should not unduly exceed
that necessary for capture because excessive current
can cause discomfort or pain. The pacemakers output-
current configuration should have sufficiently small
amplitude increments or be continuously available to
allow the user to set a current that provides reliable
capture with minimal pain or discomfort.
The pacemaker typically delivers a fixed pulse
width in the range of 20 to 40 msec for external nonin-
vasive pacemakers. Transesophageal pacemakers of-
fer an adjustable pulse width of 0 to 10 msec.
The two pacing modes are fixed rate (asynchronous)
and demand (synchronous). In fixed-rate mode, the
pacemaker delivers the electrical stimulus at preset
intervals regardless of the patients underlying cardiac
rhythm. This can have undesirable consequences: if
the heart reverts to its own rhythm, competition may
occur between the pacemaker stimuli and the natural
cardiac signals, which could cause ventricular fibrilla-
tion or reduce cardiac output. To minimize this possi-
bility, most models offer demand mode, in which the
pacing stimulus is delivered only when the monitored
heart rate is lower than the pacemakers set pacing
rate; if the pacemaker senses a heartbeat above the
pacing rate, artificial pacing stops and does not resume
unless the heart rate again drops below the pacing
rate. External noninvasive and transesophageal pace-
makers typically offer adjustable pacing rates and
continuously variable amplitudes.
2002 ECRI. Duplication of this page by any means for any purpose is prohibited.
Pacemakers, Cardiac, External
Reported problems
Transesophageal pacemakers may cause diaphrag-
matic stimulation and myocardial contracture in the
presence of electrical capture. They may also cause
vomiting, with the consequent risk of aspiration, and
difficulty in swallowing.
When an external noninvasive pacemaker is used
as a backup or standby during fluoroscopic procedures,
including monitoring of pacemaker lead insertion, the
large electrodes may obstruct the clinicians view. In
addition, certain surgical procedures preclude proper
placement of the electrodes; cardiac capture may then
be impossible or may require excessive current.
Clear recognition of capture has been a problem
with all available noninvasive pacemaker units. An
easily distinguished pacemaker artifact and a blank-
ing period to reduce noncardiac electrical response
both help recognition of capture on the ECG monitor.
Pacemakers should allow the clinician to distinguish
among the pacemaker pulse, a pacing-generated QRS
response, a muscular response, and other noise with-
out QRS response. However, users should never rely
solely on their ability to recognize capture on the ECG
monitor to determine the effectiveness of pacing the
patients clinical signs must be the deciding factor.
Noninvasive capture current typically exceeds
thresholds for both cutaneous nerve stimulation and
skeletal muscle contraction, resulting in significant
patient discomfort. Although efforts have been made
to reduce these complications, conscious patients re-
quire sedation to prevent intolerable pain and anxiety.
Purchase considerations
External noninvasive pacemakers are available in
different configurations: stand-alone pacemakers,
pacemaker/monitors, and defibrillator/monitor/
pacemakers. Depending on expected use, each unit has
significant advantages and disadvantages that should
be reviewed by a staff member who could also be
responsible for ensuring adequate staff training. Buy-
ers should check with the supplier for training pro-
gram availability. In addition, the types of patients
being treated and the users clinical protocol can influ-
ence whether fixed-rate- or demand-mode pacemakers
are needed. Also, the clinical engineering staff should
be included in the purchasing decision to help evaluate
servicing issues.
ECRI recommends that pacing capabilities be avail-
able in the emergency room, critical care unit, inten-
sive care unit, and operating room if medically
appropriate, as well as in special procedure rooms such
as cardiac catheterization laboratories. However, the
3
Healthcare Product Comparison System
routine use of this equipment throughout the hospital
can be costly and inappropriate.
Stage of development
External noninvasive and transesophageal pacing
technology has been used for cardiac resuscitation and
temporary pacing since 1952. However, the pain and
discomfort caused by early noninvasive pacemakers
could not be effectively managed using sedation. With
the advent of transvenous pacing, external noninva-
sive pacing soon fell into relative disuse.
During the 1980s, changes in electrode design,
stimulus pulse width, and electrode placement made
noninvasive pacing less painful and revived the devel-
opment of this technology. Large-surface (several
inches in diameter) electrodes reduce current density
across the skin-electrode interface; pulse widths of
about 11 msec or greater minimize the impulse ampli-
tude required for cardiac capture; and electrode place-
ment over areas of lower muscle mass lessens skeletal
muscle contractions. In addition, continuously select-
able output currents allow careful adjustments for
optimum pacing thresholds.
Both external noninvasive and transesophageal
pacing have been applied in pediatric cases for ex-
ample, during the introduction of anesthesia for pedi-
atric heart surgery and for the control of
tachyarrhythmia. Transesophageal pacing has been
used for emergency pacing of infants and children.
Both methods are more desirable than transvenous
catheter insertion for pediatric emergencies.
Bibliography
Bern AI, Pane GA, Hamilton GC. Electrical interven-
tions in cardiopulmonary resuscitation: pacing.
Emerg Med Clin North Am 1983 Dec;1(3):541-52.
Broka SM, Collard EL, Ducart AR, et al. Transeso-
phageal atrial pacing combined with dual-chamber
pacing. Anesthesiology 1996 Feb;84(2):472.
Clinton JE, Zoll PM, Zoll R, et al. Emergency noninva-
sive external cardiac pacing. J Emerg Med
1985;2(3):155-62.
Dick M 2nd, Scott WA, Serwer GS, et al. Acute termina-
tion of supraventricular tachyarrhythmias in children
by transesophageal atrial pacing. Am J Cardiol 1988
Apr 15;61(11):925-7.
External transcutaneous cardiac pacemaker downclas-
sification petition proposes user training, voluntary
standards as special controls. Med Devices Diagn In-
strum Rep Gray Sheet 1997 Mar 3;23(9):11-2.
4 2002 ECRI. Duplication of this page by any means for any purpose is prohibited.
Falk RH, Ngai ST. External cardiac pacing: influence
of electrode placement on pacing threshold. Crit
Care Med 1986 Nov;14(11):931-2.
Falk RH, Zoll PM, Zoll RH. Safety and efficacy of
noninvasive cardiac pacing. N Engl J Med 1983 Nov
10;309(19):1166-8.
Guzy PM. Emergency cardiac pacing. Emerg Med Clin
North Am 1986 Nov;4(4):745-59.
McEneaney DJ, Cochrane DJ, Anderson JA, et al.
Ventricular pacing with a novel gastroesophageal
electrode: a comparison with external pacing. Am
Heart J 1997 Jun;133(6):674-80.
Zoll PM, Zoll RH, Belgard AH. External noninvasive
electric stimulation of the heart. Crit Care Med 1981
May;9(5):393-4.
Zoll PM, Zoll RH, Falk RH, et al. External noninvasive
temporary cardiac pacing: clinical trials. Circula-
tion 1985 May;71(5):937-44.
Standards and guidelines
Note: Although every effort is made to ensure that the
following list is comprehensive, please note that other
applicable standards may exist.
American Heart Association/Australian Resuscitation
Council/European Resuscitation Council/Heart and
Stroke Foundation of Canada. Guidelines 2000 for
cardiopulmonary resuscitation and emergency car-
diovascular care. International Consensus on Sci-
ence. Circulation 2000 Aug 22;102(8):I1-380.
American National Standards Institute/Association for
the Advancement of Medical Instrumentation. Pace-
maker emergency intervention system [standard].
ANSI/AAMI PAC49-1993. 1993.
Safe current limits for electromedical apparatus
[standard]. 3rd ed. ANSI/AAMI ES1-1993. 1985 (re-
vised 1993).
British Standards Institution. Medical electrical
equipment. Particular requirements for safety.
Specification for external cardiac pacemakers with
internal power source [standard]. BS EN 60601:
part 2.31:1995. 1995.
International Electrotechnical Commission. Medical
electrical equipment part 1: general requirements
for safety [standard]. IEC 60601-1 (1988-12). 1988.
Medical electrical equipment part 1: general re-
quirements for safety. Amendment 1 [standard].
IEC 60601-1-am1 (1991-11). 1991.
 Pacemakers, Cardiac, External

Medical electrical equipment part 1: general re- Supplier information

quirements for safety. Amendment 2 [standard].
IEC 60601-1-am2 (1995-03). 1995.
CardioCommand
Medical electrical equipment part 1: general re-
quirements for safety. Section 1. Collateral standard: CardioCommand Inc [363229]
safety requirements for medical electrical systems. 4920 W Cypress St Suite H
IEC 60601-1-1 (1992-06). 1992. Tampa FL 33607
Phone: (813) 289-5555, (800) 231-6370
Medical electrical equipment part 1: general re- Fax: (813) 289-5454
quirements for safety. Section 1. Collateral standard: E-mail: awilliams@cardiocommand.com
safety requirements for medical electrical systems. Internet: http://www.cardiocommand.com
Amendment 1 [standard]. IEC 60601-1-1-am1 (1995-
11). 1995.
Medical electrical equipment part 1: general re- Galix
quirements for safety. Section 2. Collateral standard: Galix Biomedical Instrumentation Inc [176265]
electromagnetic compatibility requirements and 2555 Collins Ave Suite C-5
tests. IEC 60601-1-2 (2001-09). 2001. Miami Beach FL 33140
Medical electrical equipment part 2: particular re- Phone: (305) 534-5905
quirements for the safety of external cardiac pacemak- Fax: (305) 534-8222
ers with internal power source [standard]. IEC E-mail: galix@the-beach.net
60601-2-31 (1994-10).1994. Internet: http://www.galix-gbi.com

Medical electrical equipment part 2: particular

requirements for the safety of external cardiac pace- Lohmeier
makers with internal power source. Amendment 1
[standard]. IEC 60601-2-31am1 (1998-01). 1998. Lohmeier Medizin Elektronik GmbH + Co
[158959]
North American Society of Pacing and Electrophysiol- Fritz-Berne-Strasse 40
ogy. Recommendations of the North American Soci- D-81241 Muenchen
ety for Pacing and Electrophysiology for pacemaker Germany
and electrophysiology. PACE 1990 Apr;13:388-98. Phone: 49 (89) 8394090
Fax: 49 (89) 83940943
Underwriters Laboratories, Inc./British Standards In- E-mail: lohmeier@lohmeier.com
stitution. Medical electrical equipment, part 1: gen- Internet: http://www.lohmeier.com
eral requirements for safety [standard]. UL2601-1.
1992 (revised 1999).
Seecor

Seecor Inc [101708]

Citations from other ECRI publications
Health Devices
Defibrillator/monitors and external noninvasive pace-
makers [evaluation]. 1993 May-Jun;22(5-6):211-94.
Defibrillator/monitors and external noninvasive pace-
makers [evaluation update]. 1993 Dec;22(12):579-82.
844 Dalworth Dr Suite 6
Mesquite TX 75149
Phone: (972) 288-3278, (800) 856-1235
Fax: (972) 288-3279
Note: The following company did not provide us with
any product information in time for publication. Its
address is listed as a service to our readers.

Recording and transmitting diagnostic 12-lead ECGs Sulzer Osypka

in the prehospital environment. 1998 Feb;27(2):74. A Sulzer Medica Co [306939]
Basler Strasse 109
Health Devices Inspection and Preventive Maintenance D-79639 Grenzach-Wyhlen
System Germany
Phone: 49 (7624) 305228
Pacemakers, External Noninvasive. Procedure no. 460. Fax: 49 (7624) 305155

2002 ECRI. Duplication of this page by any means for any purpose is prohibited. 5
Healthcare Product Comparison System
About the chart specifications
The following terms are used in the chart:
Output protection: Pacemaker circuitry designed to pre-
vent excessive current from reaching the patient.
Blanking protection: Pacemaker/monitor circuitry de-
signed to change the high output pacing stimulus to
a small ECG waveform indicator.
Operating time, hr: Times indicated are for pacing only.
Recharge time, hr: Times indicated are for recharging
a 100% depleted battery.
Abbreviations:
CE mark Conformite Europeene mark
ECG Electrocardiograph
FDA U.S. Food and Drug Administration
LCD Liquid crystal display
LED Light-emitting diode
mA Milliampere
MDD Medical Devices Directive
msec Milliseconds
ppm Pulses per minute
6 2002 ECRI. Duplication of this page by any means for any purpose is prohibited.
TUV Technischer Ueberwachungs Verein
Note: The data in the charts derive from suppli-
ers specifications and have not been verified through
independent testing by ECRI or any other agency.
Because test methods vary, different products specifi-
cations are not always comparable. Moreover, prod-
ucts and specifications are subject to frequent changes.
ECRI is not responsible for the quality or validity of
the information presented or for any adverse conse-
quences of acting on such information.
When reading the charts, keep in mind that, unless
otherwise noted, the list price does not reflect supplier
discounts. And although we try to indicate which
features and characteristics are standard and which
are not, some may be optional, at additional cost.
For those models whose prices were supplied to us
in currencies other than U.S. dollars, we have also
listed the conversion to U.S. dollars to facilitate com-
parison among models. However, keep in mind that
exchange rates change often.
Need to know more?
For further information about the contents of this
Product Comparison, contact the HPCS Hotline at +1
(610) 825-6000, ext. 5265; +1 (610) 834-1275 (fax); or
hpcs@ecri.org (e-mail).
 Pacemakers, Cardiac, External

Product Comparison Chart

MODEL CARDIOCOMMAND CARDIOCOMMAND GALIX LOHMEIER

Model 2A Model 7A MA-7 P203

WHERE MARKETED Worldwide Worldwide Asia, Europe, South Worldwide, except

America Canada and USA

FDA CLEARANCE Yes Yes No No

CE MARK (MDD) No No No Yes

TYPE Transesophageal Transesophageal Transesophageal, External pacemaker

intracardiac,
electrophysiologic
stimulator

PACING MODE(S) Fixed rate, Fixed rate, Demand/fixed rate Demand/fixed rate
adjustable adjustable

PACING RATE, ppm 50-200 60-300 30-180 40-150

Continuous or
discrete settings Continuous Continuous Discrete Discrete

Number of settings NA NA 5 ppm increments 12

OUTPUT CURRENT, mA 5.5-40 0-40 0.5-25 (compliance 0-150

60 V)
Continuous or
discrete settings Continuous Continuous Discrete Continuous

Number of settings NA NA 0.5 mA increments NA

PULSE WIDTH, msec 10 0-10 0.5-25 in 0.5 msec 25

steps
OUTPUT PROTECTION Yes Yes Yes Not specified
ELECTRODES Bipolar catheter Bipolar catheter Pill electrode, Disposable adhesive
bipolar catheter, electrode with dry
quadripolar catheter gel

ECG Output adapter Output adapter Output adapter Not specified

Monitor Yes No No No

Recorder No No No No

Blanking protection No Yes Yes Not specified

DISPLAY
ECG waveform No No No No

Heart rate No No Digital on LCD No

Pacing rate Indicator light Indicator light Digital on LCD Green LED
Output current No No Digital on LCD Orange LED
Battery status Indicator light Indicator light Message on LCD Red LED (low battery
voltage)

Colons separate data on similar models of a device. This is the first of

two pages covering
the above model(s).
These specifications
continue onto the
next page.

2002 ECRI. Duplication of this page by any means for any purpose is prohibited. 7
Healthcare Product Comparison System

Product Comparison Chart

MODEL CARDIOCOMMAND CARDIOCOMMAND GALIX LOHMEIER

Model 2A Model 7A MA-7 P203

BATTERY
Type Alkaline Alkaline Two 9 V alkaline 9 V alkaline,
500 mA-hr

Operating time, hr 100 40 70 2-10, depending

on pulse rate, pulse
amplitude, impedance
Recharge time, hr NA NA NA NA

H x W x D, mm (in) 76 x 172 x 121 63.5 x 200 x 203 180 x 100 x 35 65 x 120 x 25

(3 x 6.8 x 4.8) (2.5 x 7.9 x 8) (7.1 x 4 x 1.5) (2.6 x 4.7 x 1)
WEIGHT, kg (lb) 1.3 (2.87) 0.9 (2) 0.45 (1) without 0.28 (0.62)
batteries

PURCHASE INFORMATION
List price $1,620 $2,605 $1,850 Not specified

Warranty 1 year 1 year 2 years 2 years

Delivery time, ARO Not specified Not specified 10 days 2-4 weeks

Year first sold 1994 Not specified 1990 1994

Number sold to date Not specified Not specified Not specified Not specified
Fiscal year January to December January to December April to March Not specified
OTHER SPECIFICATIONS None specified. Preamplifier adapts Rapid atrial pacing None specified.
bipolar catheter to rate from 120 to
any ECG; external 600 ppm; 3 indepen-
input jack for dent programmable
programmed extra extrastimuli for
stimuli; burst electrophysiology;
pacing up to 2 tachycardia
600 ppm. termination methods
using extrastimu-
lation; audio
indicators and
alarms. Meets
requirements of TUV.

Colons separate data on similar models of a device.

8 2002 ECRI. Duplication of this page by any means for any purpose is prohibited.
 Pacemakers, Cardiac, External

Product Comparison Chart

MODEL SEECOR SEECOR

STAT-PACE II STAT-PACE II (in

clamshell case)
WHERE MARKETED Worldwide Worldwide

FDA CLEARANCE Yes Yes

CE MARK (MDD) No No

TYPE Transesophageal Transesophageal

pacemaker pacemaker

PACING MODE(S) Fixed rate Fixed rate

PACING RATE, ppm 50-800 50-800

Continuous or
discrete settings Continuous Continuous

Number of settings NA NA

OUTPUT CURRENT, mA 5.5-60 5.5-60

Continuous or
discrete settings Continuous Continuous

Number of settings NA NA

PULSE WIDTH, msec 2-10 2-10

OUTPUT PROTECTION Yes Yes

ELECTRODES Compatible with any Compatible with any
bipolar catheter bipolar catheter
and Arzco pill and Arzco pill
electrodes electrodes

ECG Output adapter Output adapter

Monitor No No

Recorder No No

Blanking protection No No
DISPLAY
ECG waveform No No

Heart rate Indicator light Indicator light

Pacing rate Indicator light Indicator light

Output current No No
Battery status Indicator light Indicator light

Colons separate data on similar models of a device. This is the first of

two pages covering
the above model(s).
These specifications
continue onto the
next page.

2002 ECRI. Duplication of this page by any means for any purpose is prohibited. 9
Healthcare Product Comparison System

Product Comparison Chart

MODEL SEECOR SEECOR

STAT-PACE II STAT-PACE II (in

clamshell case)
BATTERY
Type Disposable alkaline Disposable alkaline

Operating time, hr 100 100

Recharge time, hr NA NA

H x W x D, mm (in) 218 x 156 x 96 114 x 305 x 241

(8.6 x 6.1 x 3.9) (4.5 x 12 x 9.5)
WEIGHT, kg (lb) 2.27 (5) 2.3 (5.07)

PURCHASE INFORMATION
List price $3,450 $3,450

Warranty 1 year 1 year

Delivery time, ARO 2 weeks 2 weeks

Year first sold 1993 1986

Number sold to date Not specified Not specified

Fiscal year January to December January to December
OTHER SPECIFICATIONS Burst pacing up to Burst pacing up to
800 ppm; overdrive 800 ppm; overdrive
pacing (50-800 ppm); pacing (50-800 ppm);
temporary pacing. temporary pacing.

Colons separate data on similar models of a device.

10 2002 ECRI. Duplication of this page by any means for any purpose is prohibited.